hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 21:04:30 - browse：7

Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill. -- health policy coverage from STAT — Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill in 2021. Susan Walsh/AP

WASHINGTON — One of the top health care committees in the Senate is assembling ideas for bipartisan legislation to address drug shortages, three Senate aides and three lobbyists told STAT.

The talks, led by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) are in the early days, but they could move the debate over drug shortage reforms into a new phase. The committee has jurisdiction over Medicare and Medicaid payment policies for hospitals. Other committees that have tried tackling the issue have jurisdiction mostly over the Food and Drug Administration.

The panel is tentatively aiming to hold a hearing on the issue in November, the sources said. The panel has also started accepting input from outside stakeholders, one lobbyist said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Focused ultrasound for uterine fibroids: an uphill battle

focus

entertainment

WSS

iTeos Therapeutics debuts first data on TIGIT

Heat waves linked to early deliveries, preterm births in new study

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Food makers to regulators: Ultra

PEPFAR is under serious threat — and so is global health

Average age of first period drops to 11.9 years, study shows

knowledge

hotspot

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

PEPFAR is under serious threat — and so is global health

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Walensky prepares to leave CDC — and Congress — behind

Acelyrin, a rare IPO success, stumbles in its first big test

United colonoscopy coverage change 'may cost lives,' doctors say

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

At least 13 dead in Texas as scorching temps continue

What to make of Biden’s latest efforts on cancer research

explore

New weight loss drugs vying to be the next Wegovy or Mounjaro

Stigma and the return of syphilis

Diverse clinical trials: Why aren’t we there yet?

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Do more moles mean more problems? Not so, says new study

Average age of first period drops to 11.9 years, study shows

focus

entertainment

leisure time

entertainment